Description

(8β)-n-[3-(Methylamino)Propyl]-6-(2-Propenyl)-Ergoline-8-Carboxamide CAS NO 478815-26-8 is a complex ergoline alkaloid derivative, a class of compounds known for their significant biological activity. This compound is of high interest in advanced pharmaceutical research and development, particularly for its potential as a key intermediate or active pharmaceutical ingredient (API). It is primarily sought by research institutions, pharmaceutical companies, and fine chemical manufacturers engaged in the synthesis of novel therapeutics targeting neurological and cardiovascular systems. Our supply is characterized by stringent quality control to ensure consistency and reliability for critical research and production processes.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel ergot-based pharmaceuticals.
• Neurological Research: Used in preclinical studies to investigate compounds for central nervous system (CNS) disorders.
• Cardiovascular Drug Development: Explored for potential applications in developing treatments for hypertension and migraines.
• Biochemical Research: Employed as a reference standard or ligand in receptor binding assays and pharmacological studies.
• Fine Chemical Synthesis: Utilized in custom synthesis and process development for specialized chemical entities.
• Academic Research: Supports chemical and pharmacological research in university and institutional laboratories.

Basic Information

Product Name	(8β)-n-[3-(Methylamino)Propyl]-6-(2-Propenyl)-Ergoline-8-Carboxamide
CAS No.	478815-26-8
Molecular Formula	C22H30N4O
Molecular Weight	366.50 g/mol
Synonyms	6-Allyl-8β-[N-(3-methylaminopropyl)]carboxamidolysergol; 6-Allyl-8β-carbamoyl-N-(3-methylaminopropyl)lysergol; 8β-[N-(3-Methylaminopropyl)]carboxamido-6-allylergoline; (8β)-N-[3-(Methylamino)propyl]-6-(2-propen-1-yl)ergoline-8-carboxamide; 6-Allyl-8β-carboxyamido-N-(3-methylaminopropyl)lysergol; Ergoline-8-carboxamide, N-[3-(methylamino)propyl]-6-(2-propen-1-yl)-, (8β)-; Contact for additional trade names.
EINECS	Contact for details

Quality Control

Our (8β)-n-[3-(Methylamino)Propyl]-6-(2-Propenyl)-Ergoline-8-Carboxamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high-purity standards required for research and development. Certificates of Analysis (COA) detailing batch-specific results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.